-
1
-
-
0024239135
-
Hospital acquired candidemia: The attributable mortality and excess length of stay
-
1. Wey SB, Mori M, Pfaller MA, et al. Hospital acquired candidemia: The attributable mortality and excess length of stay. Arch Intern Med. 1988;148:2642-2645.
-
(1988)
Arch Intern Med.
, vol.148
, pp. 2642-2645
-
-
Wey, S.B.1
Mori, M.2
Pfaller, M.A.3
-
2
-
-
0024450044
-
Risk factors for hospital-acquired candidemia. A matched case-control study
-
2. Wey SB, Mori M, Pfaller MA, et al. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 1989;149:2349-2353.
-
(1989)
Arch Intern Med.
, vol.149
, pp. 2349-2353
-
-
Wey, S.B.1
Mori, M.2
Pfaller, M.A.3
-
3
-
-
0028241340
-
Noscomial bloodstream infection in critcally ill patients. Excess length of stay, extra costs, and attributable mortality
-
3. Pittet D, Tarara D, Wenzel RP. Noscomial bloodstream infection in critcally ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271:1598-1601.
-
(1994)
JAMA
, vol.271
, pp. 1598-1601
-
-
Pittet, D.1
Tarara, D.2
Wenzel, R.P.3
-
4
-
-
0001932135
-
Definitions of Candida infections
-
Bodey GP, ed. . New York: Raven Press
-
4. Bodey GP, Anaissie EJ, Edwards JE. Definitions of Candida infections. In: Bodey GP, ed. Candidiasis: Pathogenesis, Diagnosis, and Treatment. New York: Raven Press; 1993:407-408.
-
(1993)
Candidiasis: Pathogenesis, Diagnosis, and Treatment
, pp. 407-408
-
-
Bodey, G.P.1
Anaissie, E.J.2
Edwards, J.E.3
-
5
-
-
0022116795
-
Fungemia in a cancer hospital: Changing frequency, earlier onset, and results of therapy
-
5. Horn R, Wong B, Kiehn TE, Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis. 1985;7:646-655.
-
(1985)
Rev Infect Dis.
, vol.7
, pp. 646-655
-
-
Horn, R.1
Wong, B.2
Kiehn, T.E.3
Armstrong, D.4
-
6
-
-
0027436166
-
Improved survival from fungaemia in patients with haematological malignancies: Analysis of risk factors for death and usefulness of early antifungal therapy
-
6. Iwama A, Yoshida M, Miwa A, et al. Improved survival from fungaemia in patients with haematological malignancies: analysis of risk factors for death and usefulness of early antifungal therapy. Eur J Haematol. 1993;51:156-160.
-
(1993)
Eur J Haematol.
, vol.51
, pp. 156-160
-
-
Iwama, A.1
Yoshida, M.2
Miwa, A.3
-
7
-
-
0018742009
-
Hospital-acquired fungemia: Its natural course and clinical significance
-
7. Klein JJ, Watanakunakorn C. Hospital-acquired fungemia: its natural course and clinical significance. Am J Med. 1979;67:51-58.
-
(1979)
Am J Med.
, vol.67
, pp. 51-58
-
-
Klein, J.J.1
Watanakunakorn, C.2
-
8
-
-
0024672797
-
Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: Frequency, characteristics, and evaluation of factors influencing outcome
-
8. Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis. 1989;11:379-390.
-
(1989)
Rev Infect Dis.
, vol.11
, pp. 379-390
-
-
Komshian, S.V.1
Uwaydah, A.K.2
Sobel, J.D.3
Crane, L.R.4
-
9
-
-
0026549608
-
Vascular catheter-associated fungemia in patients with cancer: Analysis of 155 episodes
-
9. Lecciones JA, Lee JW, Navarro EE, et al. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis. 1992;14:875-883.
-
(1992)
Clin Infect Dis.
, vol.14
, pp. 875-883
-
-
Lecciones, J.A.1
Lee, J.W.2
Navarro, E.E.3
-
10
-
-
0021752619
-
Systemic candidiasis in cancer patients
-
10. Maksymiuk AW, Thonprasert S, Hopfer R, et al. Systemic candidiasis in cancer patients. Am J Med. 1984;77(4D):20-27.
-
(1984)
Am J Med.
, vol.77
, Issue.4 D
, pp. 20-27
-
-
Maksymiuk, A.W.1
Thonprasert, S.2
Hopfer, R.3
-
12
-
-
0028806984
-
Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study
-
12. Nguyen MH, Peacock JE Jr, Tanner DC, et al. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med. 1995;155:2429-2435.
-
(1995)
Arch Intern Med.
, vol.155
, pp. 2429-2435
-
-
Nguyen, M.H.1
Peacock J.E., Jr.2
Tanner, D.C.3
-
13
-
-
0017654361
-
Bacteremia and fungemia complicating neoplastic disease: A study of 364 cases
-
13. Singer C, Kaplan MH, Armstrong D. Bacteremia and fungemia complicating neoplastic disease: a study of 364 cases. Am J Med. 1977;62:731-742.
-
(1977)
Am J Med.
, vol.62
, pp. 731-742
-
-
Singer, C.1
Kaplan, M.H.2
Armstrong, D.3
-
14
-
-
0023614408
-
Bacteremia and fungemia in patients with neoplastic disease
-
14. Whimbey E, Kiehn TE, Brannon P, et al. Bacteremia and fungemia in patients with neoplastic disease. Am J Med. 1987;82:723-730.
-
(1987)
Am J Med.
, vol.82
, pp. 723-730
-
-
Whimbey, E.1
Kiehn, T.E.2
Brannon, P.3
-
16
-
-
0026737730
-
Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality
-
16. Fraser VJ, Jones M, Dunkel J, et al. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis. 1992;15:414-421.
-
(1992)
Clin Infect Dis.
, vol.15
, pp. 414-421
-
-
Fraser, V.J.1
Jones, M.2
Dunkel, J.3
-
17
-
-
0028046352
-
A randomized trial comparing fluconazole with amphotericin b for the treatment of candidemia in patients without neutropenia
-
17. Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. NEJM. 1994;331:1325-1330.
-
(1994)
NEJM
, vol.331
, pp. 1325-1330
-
-
Rex, J.H.1
Bennett, J.E.2
Sugar, A.M.3
-
18
-
-
0010642815
-
Fluconazole (FLU) versus amphotericin B (AMB) for candidemia in non-neutropenic patients: A multicenter randomized trial
-
Abstract No. LM20
-
18. Phillips P, Shafran S, Garber G, et al. Fluconazole (FLU) versus amphotericin B (AMB) for candidemia in non-neutropenic patients: a multicenter randomized trial. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1995, Abstract No. LM20.
-
(1995)
35th Interscience Conference on Antimicrobial Agents and Chemotherapy
-
-
Phillips, P.1
Shafran, S.2
Garber, G.3
-
19
-
-
0028865579
-
Intravascular catheter exchanges and the duration of candidemia
-
19. Rex JH, Bennett JE, Sugar AM, et al. Intravascular catheter exchanges and the duration of candidemia. Clin Infect Dis. 1995;21: 994-996.
-
(1995)
Clin Infect Dis.
, vol.21
, pp. 994-996
-
-
Rex, J.H.1
Bennett, J.E.2
Sugar, A.M.3
-
20
-
-
0021739699
-
A simplified acute physiology score for ICU patients
-
20. Le Gall J-R, Loirat P, Alperovitch A, et al. A simplified acute physiology score for ICU patients. Crit Care Med. 1984;11:975-977.
-
(1984)
Crit Care Med.
, vol.11
, pp. 975-977
-
-
Le Gall, J.-R.1
Loirat, P.2
Alperovitch, A.3
-
21
-
-
0026409568
-
The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults
-
21. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619-1636.
-
(1991)
Chest
, vol.100
, pp. 1619-1636
-
-
Knaus, W.A.1
Wagner, D.P.2
Draper, E.A.3
-
22
-
-
0026048714
-
The pathogenesis of sepsis
-
22. Bone RC. The pathogenesis of sepsis. Ann Intern Med. 1993;115: 457-469.
-
(1993)
Ann Intern Med.
, vol.115
, pp. 457-469
-
-
Bone, R.C.1
-
23
-
-
10344251462
-
Management of invasive candidal infections: Results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature
-
23. Anaissie EJ, Darouiche RO, Abi-Said D, et al. Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature. Clin Infect Dis. 1996;23:964-972.
-
(1996)
Clin Infect Dis.
, vol.23
, pp. 964-972
-
-
Anaissie, E.J.1
Darouiche, R.O.2
Abi-Said, D.3
-
24
-
-
0017734445
-
A semiquantitative culture method for identifying intravenous-catheter related infection
-
24. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter related infection. NEJM. 1977;23:1305-1309.
-
(1977)
NEJM
, vol.23
, pp. 1305-1309
-
-
Maki, D.G.1
Weise, C.E.2
Sarafin, H.W.3
-
25
-
-
0027361922
-
Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection
-
25. Berenguer J, Buck M, Witebsky F, et al. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn Microbiol Infect Dis. 1993;17:103-109.
-
(1993)
Diagn Microbiol Infect Dis.
, vol.17
, pp. 103-109
-
-
Berenguer, J.1
Buck, M.2
Witebsky, F.3
-
26
-
-
0242437957
-
Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: A matched cohort study
-
26. Anaissie EJ, Vartivarian SE, Abi-Said D, et al. Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. Am J Med. 1996;101:170-176.
-
(1996)
Am J Med.
, vol.101
, pp. 170-176
-
-
Anaissie, E.J.1
Vartivarian, S.E.2
Abi-Said, D.3
-
27
-
-
0013915404
-
Fungal infections complicating acute leukemia
-
27. Bodey GP. Fungal infections complicating acute leukemia. J Chron Dis. 1966;19:667-687.
-
(1966)
J Chron Dis.
, vol.19
, pp. 667-687
-
-
Bodey, G.P.1
-
28
-
-
0031157777
-
The epidemiology of hematogenous candidiasis caused by different candida species
-
28. Abi-Said D, Anaissie E, Uzun O, et al. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis. 1997;24:1122-1128.
-
(1997)
Clin Infect Dis.
, vol.24
, pp. 1122-1128
-
-
Abi-Said, D.1
Anaissie, E.2
Uzun, O.3
-
29
-
-
0019408067
-
Fungemia in the immunocompromised host: Changing patterns, antigenemia, high mortality
-
29. Meunier-Carpentier F, Kiehn TE, Armstrong D. Fungemia in the immunocompromised host: changing patterns, antigenemia, high mortality. Am J Med. 1981;71:363-370.
-
(1981)
Am J Med.
, vol.71
, pp. 363-370
-
-
Meunier-Carpentier, F.1
Kiehn, T.E.2
Armstrong, D.3
-
30
-
-
0019941467
-
Bacteremias and fungemias in oncologic patients with central venous catheters. Changing spectrum of infection
-
30. Lowder JN, Lazarus HM, Herzig RH. Bacteremias and fungemias in oncologic patients with central venous catheters. Changing spectrum of infection. Arch Intern Med. 1982;142:1456-1459.
-
(1982)
Arch Intern Med.
, vol.142
, pp. 1456-1459
-
-
Lowder, J.N.1
Lazarus, H.M.2
Herzig, R.H.3
-
31
-
-
0023881269
-
Risk factors for candidemia in cancer patients: A case-control study
-
31. Karabinis A, Hill C, Leclerq B, et al. Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol. 1988;26:429-432.
-
(1988)
J Clin Microbiol.
, vol.26
, pp. 429-432
-
-
Karabinis, A.1
Hill, C.2
Leclerq, B.3
-
32
-
-
0029154002
-
Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: The pathogenetic role of the antileukemic regimen
-
32. Bow EJ, Loewen R, Cheang MS, Schacter B. Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen. Clin Infect Dis. 1995;21:361-369.
-
(1995)
Clin Infect Dis.
, vol.21
, pp. 361-369
-
-
Bow, E.J.1
Loewen, R.2
Cheang, M.S.3
Schacter, B.4
-
33
-
-
0020360770
-
Candida infections in patients with acute leukemia: Ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis
-
33. DeGregorio MW, Lee WMF, Ries CA. Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis. Cancer. 1982;50:2780-2784.
-
(1982)
Cancer
, vol.50
, pp. 2780-2784
-
-
DeGregorio, M.W.1
Lee, W.M.F.2
Ries, C.A.3
|